Trials / Completed
CompletedNCT00348062
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Evaluate the incidence of hyperemia in patients using bimatoprost and to determine if simple interventions reduce its incidence and to assess the value of detailed instruction in increasing patient compliance and willingness to continue bimatoprost therapy, despite the occurrence of hyperemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bimatoprost |
Timeline
- First posted
- 2006-07-04
- Last updated
- 2007-06-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00348062. Inclusion in this directory is not an endorsement.